Home > Healthcare > Cardiac Marker Testing Market > Table of Contents

Cardiac Marker Testing Market - By Product (Consumables, Analyzers), By Biomarker Type (Troponins, Myoglobin, Creatine kinase), By Application (Myocardial Infarction, Congestive Heart Failure, Atherosclerosis), By Distribution Channel, By End-use & Forecast, 2023 – 2032

  • Report ID: GMI5614
  • Published Date: May 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope & definition

1.3    Base estimates & calculations

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data Sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Cardiac marker testing industry 360º synopsis, 2018 – 2032

2.2    Business trends

2.3    Regional trends

2.4    Product trends

2.5    Biomarker type trends

2.6    Application trends

2.7    Distribution channel trends

2.8    End-use trends

Chapter 3   Cardiac Marker Testing Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Growing prevalence of cardiovascular diseases

3.2.1.2   Technological advancements

3.2.1.3   Increasing funding from public and private organizations for R&D

3.2.1.4   Rising demand for point-of-care (POC) testing

3.2.1.5   Increasing government initiatives for the diagnosis of cardiac diseases

3.2.2    Industry pitfalls & challenges

3.2.2.1   Stringent regulatory frameworks

3.2.2.2   Lack of skilled professionals

3.2.2.3   Availability of substitute product

3.3    Growth potential analysis

3.3.1    By product

3.3.2    By biomarker type

3.3.3    By application

3.3.4    By distribution channel

3.3.5    By end use

3.4    COVID- 19 impact analysis

3.5    Pricing analysis, 2022

3.6    Regulatory landscape

3.6.1    U.S.

3.6.2    Europe

3.7    Technology landscape

3.8    Future market trends

3.9    Gap analysis

3.10    Porter's analysis

3.11    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Company market share analysis, 2022

4.4    Competitive positioning matrix

4.5    Vendor matrix analysis

4.6    Strategy dashboard

Chapter 5   Cardiac Marker Testing Market Size and Forecast, By Product (USD Million & Units)

5.1    Key trends, by product

5.2    Consumables

5.3    Analyzers

Chapter 6   Cardiac Marker Testing Market Size and Forecast, By Biomarker Type (USD Million)

6.1    Key trends, by biomarker type

6.2    Troponins

6.3    Myoglobin

6.4    Creatine kinase (CK-MB)

6.5    Brain natriuretic peptide (BNP)

6.6    Ischemia modified albumin (IMA)

6.7    Others

Chapter 7   Cardiac Marker Testing Market Size and Forecast, By Application (USD Million)

7.1    Key trends, by application

7.2    Myocardial infarction

7.3    Congestive heart failure

7.4    Acute coronary syndrome

7.5    Atherosclerosis

7.6    Others

Chapter 8   Cardiac Marker Testing Market Size and Forecast, By Distribution Channel (USD Million)

8.1    Key trends, by distribution channel

8.2    Hospital pharmacies

8.3    Brick & mortar

8.4    E-commerce

Chapter 9   Cardiac Marker Testing Market Size and Forecast, By End-use (USD Million)

9.1    Key trends, by end-use

9.2    Hospitals

9.3    Diagnostic centers

9.4    Others

Chapter 10   Cardiac Marker Testing Market Size and Forecast, By Region (USD Million)

10.1    Key trends, by region

10.2    North America

10.2.1    U.S.

10.2.2    Canada

10.3    Europe

10.3.1    Germany

10.3.2    UK

10.3.3    France

10.3.4    Spain

10.3.5    Italy

10.3.6    Poland

10.3.7    Sweden

10.3.8    The Netherlands

10.4    Asia Pacific

10.4.1    Japan

10.4.2    China

10.4.3    India

10.4.4    Australia

10.4.5    South Korea

10.4.6    Thailand

10.4.7    Indonesia

10.4.8    Philippines

10.5    Latin America

10.5.1    Brazil

10.5.2    Mexico

10.5.3    Argentina

10.5.4    Columbia

10.5.5    Chile

10.5.6    Peru

10.6    MEA

10.6.1    South Africa

10.6.2    Saudi Arabia

10.6.3    UAE

10.6.4    Israel

10.6.5    Turkey

10.6.6    Iran

Chapter 11   Company Profiles

11.1    Abbott

11.2    Becton, Dickinson and Company

11.3    Biomérieux SA

11.4    Bio-Rad Laboratories, Inc.

11.5    Creative Diagnostics

11.6    Danaher Corporation

11.7    F. Hoffmann-La Roche Ltd.

11.8    Life Diagnostics

11.9    Perkin Elmer Inc.

11.10    Quidel Corporation

11.11    Randox Laboratories Ltd.

11.12    Siemens Healthineers

11.13    Thermo Fisher Scientific
 

Authors: Mariam Faizullabhoy

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 529
  • Countries covered: 30
  • Pages: 280
 Download PDF